A quarterly journal on cancer titled Applied Radiation Oncology stated that Ene received the award at the 2019 American Association of Neurological Surgeons (AANS) annual scientific meeting which held from April 13 to April 17 in San Diego, US.
Ene who is presently 37, hails from Akpugo in Nkanu west local government area of Enugu state. He won the award with his research work titled: “Anti-PD-L1 Immunotherapy Enhances Radiation-induced Abscopal Response in Glioblastoma”.
Dr. Chibanwanye Ene |
Immunotherapy for glioblastoma has been largely unsuccessful in part because molecular heterogeneity drives selective elimination of only a subset of tumour cells.
According to the journal, the molecular structure of the tumor found in that form of cancer only allows few of the cancerous cells to be eliminated during treatment.
Promise for better treatment options was shown in the new findings in Ene's research, which revealed that “radiation combined with Anti PD L1 therapy induces an immunological response to unirradiated glioblastoma”
The Journal further revealed that the:
The researchers are currently optimizing other treatment combinations that could also be readily assessed in phase I human clinical trials.